Bactiguard Holding Ab Stock Current Valuation
| BACTI-B Stock | SEK 37.00 1.70 4.82% |
Valuation analysis of Bactiguard Holding helps investors to measure Bactiguard Holding's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Bactiguard Holding's price fluctuation is very steady at this time. Calculation of the real value of Bactiguard Holding is based on 3 months time horizon. Increasing Bactiguard Holding's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bactiguard Holding is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bactiguard Stock. However, Bactiguard Holding's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 37.0 | Real 34.71 | Hype 37.0 | Naive 39.89 |
The real value of Bactiguard Stock, also known as its intrinsic value, is the underlying worth of Bactiguard Holding Company, which is reflected in its stock price. It is based on Bactiguard Holding's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bactiguard Holding's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bactiguard Holding AB helps investors to forecast how Bactiguard stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bactiguard Holding more accurately as focusing exclusively on Bactiguard Holding's fundamentals will not take into account other important factors: Bactiguard Holding AB Company Current Valuation Analysis
Bactiguard Holding's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Bactiguard Holding Current Valuation | 3.96 B |
Most of Bactiguard Holding's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bactiguard Holding AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Bactiguard Holding AB has a Current Valuation of 3.96 B. This is 72.42% lower than that of the Healthcare sector and 68.11% lower than that of the Medical Devices industry. The current valuation for all Sweden stocks is 76.17% higher than that of the company.
Bactiguard Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bactiguard Holding's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bactiguard Holding could also be used in its relative valuation, which is a method of valuing Bactiguard Holding by comparing valuation metrics of similar companies.Bactiguard Holding is currently under evaluation in current valuation category among its peers.
Bactiguard Fundamentals
| Return On Equity | -0.1 | |||
| Return On Asset | -0.0369 | |||
| Profit Margin | (0.23) % | |||
| Operating Margin | (0.21) % | |||
| Current Valuation | 3.96 B | |||
| Shares Outstanding | 31.04 M | |||
| Shares Owned By Insiders | 44.20 % | |||
| Shares Owned By Institutions | 39.71 % | |||
| Price To Earning | (75.59) X | |||
| Price To Book | 7.68 X | |||
| Price To Sales | 19.30 X | |||
| Revenue | 169.49 M | |||
| Gross Profit | 188.58 M | |||
| EBITDA | (7.88 M) | |||
| Net Income | (58.77 M) | |||
| Cash And Equivalents | 217.59 M | |||
| Cash Per Share | 0.11 X | |||
| Total Debt | 238.31 M | |||
| Debt To Equity | 65.80 % | |||
| Current Ratio | 1.67 X | |||
| Book Value Per Share | 14.14 X | |||
| Cash Flow From Operations | 7.26 M | |||
| Earnings Per Share | (1.83) X | |||
| Target Price | 40.0 | |||
| Number Of Employees | 212 | |||
| Beta | -0.22 | |||
| Market Capitalization | 3.42 B | |||
| Total Asset | 849.29 M | |||
| Retained Earnings | (279 M) | |||
| Working Capital | (127 M) | |||
| Current Asset | 101 M | |||
| Current Liabilities | 228 M | |||
| Z Score | 8.4 | |||
| Net Asset | 849.29 M |
About Bactiguard Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bactiguard Holding AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bactiguard Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bactiguard Holding AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Bactiguard Stock
Bactiguard Holding financial ratios help investors to determine whether Bactiguard Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bactiguard with respect to the benefits of owning Bactiguard Holding security.